树突细胞癌疫苗:用于癌症免疫治疗的临床生产
Hoyoung M Maeng1, Purevdorj B Olkhanud2, Mary Black3
1Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. hoyoung.maeng@nih.gov.
Methods in molecular biology (Clifton, N.J.)
|April 23, 2025
概括
这项研究详细介绍了从患者单细胞制造树突细胞 (DC) 癌症疫苗的方法. 这些工程化DC可以克服瘤微环境中DC成熟度差的挑战,提供了一个有前途的癌症免疫治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 树突细胞 (DC) 癌症疫苗旨在提高抗瘤免疫力.
- 癌症患者的DCs通常在瘤微环境中表现出受损的成熟.
- 由于数量较少和纯度问题,对成熟的外围直流电源的隔离具有挑战性.
研究的目的:
- 描述生成自身树突细胞 (DC) 癌症疫苗的程序.
- 克服癌症患者体内DC成熟的局限性.
- 提供一种可扩展的方法,从血液单细胞中产生治疗性DC.
主要方法:
- 通过非和化收集周围血液单细胞.
- 单细胞在体外分化和扩张成DCs.
- 使用脉冲或病毒载体转导 (例如,腺病毒) 将抗原加载到DC上.
- 在实验室中成熟的抗原载荷DCs.
- 给患者使用成熟的DC.
主要成果:
- 从单细胞生成临床级DCs的建立协议.
- 证明了在DC中有效表达抗原的方法.
- 开发了用于DC疫苗生产的可重复工艺.
结论:
- 自体DC疫苗可以从外围血液单细胞生成.
- 这种方法绕过了瘤微环境中DC成熟度差的问题.
- 描述的程序为树突细胞癌疫苗开发提供了一个可行的策略.
相关概念视频
Cancer Vaccines
237
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
237
Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397


